Glaucoma

CHICAGO — Evidence suggests that selective laser trabeculoplasty could be the standard of care for patients with glaucoma, according to a speaker here.

CHICAGO — In this video from Eyecelerator@AAO, SpyGlass Pharma CEO Patrick Mooney discusses the company’s drug delivery platform, which lowered IOP in patients with open-angle glaucoma or ocular hypertension.

CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Shawn O’Neil of ViaLase discusses the company’s noninvasive OCT-driven femtosecond laser for glaucoma treatment.

MILAN — During iNovation Day at the ESCRS meeting, Philippe Sourdille, MD, presented the Cilio-scleral Inter-positioning Device from Ciliatech for the surgical treatment of glaucoma.

Santen and UBE announced the FDA approval of Omlonti for the reduction of elevated IOP in patients with primary open-angle glaucoma or ocular hypertension.

LAS VEGAS – A variety of glaucoma and cataract technologies in the pipeline now will help optometric patients in the future, Justin A. Schweitzer, OD, FAAO, of Vance Thompson Vision Center in Sioux Falls, S.D., said at Vision Expo West.

LAS VEGAS – Consumers ranked contact lenses and eyeglasses as very important to them in a survey commissioned by the Contact Lens Institute that asked respondents to rate 26 products and services.

LAS VEGAS — Educating patients through community outreach and finding ways to show them their ocular issues may help address racial disparities in eye care and access to innovations, according to a presentation at Vision Expo West.

LAS VEGAS – Some glaucoma risk factors are not related to IOP, highlighting the need for new therapeutic options that address other aspects of the disease process, Jessica Steen, OD, FAAO, said at Vision Expo West.

Corneal hysteresis measurements remained stable in patients with glaucoma during routine follow-up and after cataract surgery over a 6-month period, according to an analysis published in the Journal of Glaucoma.